Clinical Trial

Al18F-NOTA-LM3 PET/CT in Patients With TIO

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 26, 2026 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a pilot study to assess the value of whole-body Al18F-NOTA-LM3 PET/CT in patients with tumor-induced osteomalacia.
Trial Details
NCT Number NCT07366099
Lead Sponsor Peking Union Medical College Hospital
Conditions Tumor-Induced Osteomalacia
Enrollment 40 participants
Start Date 2023-03-30
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-26